[Value of a log book for patients receiving intravitreal injections]
J Fr Ophtalmol
.
2023 Dec;46(10):e398-e400.
doi: 10.1016/j.jfo.2023.07.021.
Epub 2023 Nov 7.
[Article in French]
Authors
J Dekeyser
1
,
M Sfaxi
2
,
M Legros
2
,
J C Quintyn
2
Affiliations
1
Service ophtalmologie, CHU de Caen, avenue de la Côte-de-Nacre, 14000 Caen, France. Electronic address: dekeyser-j@chu-caen.fr.
2
Service ophtalmologie, CHU de Caen, avenue de la Côte-de-Nacre, 14000 Caen, France.
PMID:
37945428
DOI:
10.1016/j.jfo.2023.07.021
No abstract available
Publication types
Letter
MeSH terms
Angiogenesis Inhibitors* / adverse effects
Bevacizumab
Humans
Intravitreal Injections
Ranibizumab*
Retrospective Studies
Substances
Angiogenesis Inhibitors
Ranibizumab
Bevacizumab